Skip to main content
. 2023 Feb 15;9(3):e13753. doi: 10.1016/j.heliyon.2023.e13753

Fig. 2.

Fig. 2

CUMS induces marked tumor growth in CLM. (A) HT29+HSC-CUMS and HT29+HSC-control tumor size was compared. (B) MVD in HT29+HSC-CUMS and HT29+HSC-control group. (C) Masson's trichrome staining of xenograft. Data are presented as the mean ± S.E.M. *P < 0.05, **P < 0.01, ***P < 0.001.